Oracle's Massive Debt Problem: Risks for Investors
Oracle’s massive debt problem isn’t just a headline. In this guide, we break down the debt load, its possible payback...
Need a credit card that rewards you for gas purchases? Explore our recommendations for the best cash back options available.
28,303 articlesOracle’s massive debt problem isn’t just a headline. In this guide, we break down the debt load, its possible payback...
Once-skeptical of SaaS valuations, this longtime saas bear now highlights real value in beaten-down software. He shar...
A stock that’s fallen dramatically yet still pays a solid dividend invites careful scrutiny. Here’s a practical, numb...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
Investing in mobile infrastructure requires understanding the earnings engine behind 5G networks. This guide breaks d...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
Critics have labeled this stock as overvalued for years, yet its price action and earnings trajectory tell a differen...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
When fear takes the wheel, investors often forget the basics. This guide lays out three practical reminders to stay t...
QUBT surged alongside quantum peers on policy chatter, but the rally raises questions about fundamentals and governme...
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...